Baupost Group Q2 2016 holdings

$7.37 Billion is the total value of Baupost Group's 39 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 47.2% .

 Value Shares↓ Weighting
EMC BuyE M C CORP MASS$1,547,650
+12.0%
56,961,725
+9.9%
21.01%
+5.3%
LNG  CHENIERE ENERGY INC$1,120,536
+11.0%
29,841,1740.0%15.21%
+4.3%
VSAT  VIASAT INC$823,466
-2.8%
11,533,1370.0%11.18%
-8.7%
AGN BuyALLERGAN PLC$462,637
+0.3%
2,001,978
+16.3%
6.28%
-5.8%
AR SellANTERO RES CORP$376,863
-29.5%
14,505,881
-32.5%
5.12%
-33.8%
OLN  OLIN CORP$266,762
+43.0%
10,739,2020.0%3.62%
+34.4%
PBF  PBF ENERGY INCcl a$253,047
-28.4%
10,641,1750.0%3.44%
-32.7%
C NewCITIGROUP INC$219,0295,167,000
+100.0%
2.97%
FOXA  TWENTY FIRST CENTY FOX INCcl a$208,202
-3.0%
7,696,9220.0%2.83%
-8.8%
PYPL SellPAYPAL HLDGS INC$206,796
-24.1%
5,664,087
-19.8%
2.81%
-28.7%
FOX  TWENTY FIRST CENTY FOX INCcl b$198,328
-3.4%
7,278,1000.0%2.69%
-9.2%
INVA SellINNOVIVA INC$185,434
-25.7%
17,610,091
-11.1%
2.52%
-30.1%
KERX  KERYX BIOPHARMACEUTICALS INC$170,741
+41.8%
25,791,6780.0%2.32%
+33.3%
TBPH BuyTHERAVANCE BIOPHARMA INC$166,794
+36.5%
7,350,991
+13.1%
2.26%
+28.3%
VMW  VMWARE INC$128,899
+9.4%
2,252,6940.0%1.75%
+2.8%
ATRA  ATARA BIOTHERAPEUTICS INC$120,645
+18.3%
5,359,6320.0%1.64%
+11.2%
VRTV  VERITIV CORP$114,408
+0.9%
3,044,3850.0%1.55%
-5.2%
FWP  FORWARD PHARMA A/Ssponsored adr$97,524
+6.9%
5,367,3000.0%1.32%
+0.5%
LVNTA NewLIBERTY INTERACTIVE CORP$91,5462,469,533
+100.0%
1.24%
R114PS  CHIPMOS TECH BERMUDA LTD$67,946
+4.2%
3,751,8530.0%0.92%
-2.1%
KLXI  KLX INC$62,000
-3.5%
2,000,0000.0%0.84%
-9.3%
NG SellNOVAGOLD RES INC$58,140
-23.1%
9,500,000
-36.7%
0.79%
-27.7%
CAR NewAVIS BUDGET GROUP$57,6021,787,227
+100.0%
0.78%
SEMI  SUNEDISON SEMICONDUCTOR LTD$49,652
-8.5%
8,372,9790.0%0.67%
-14.0%
AIGWS BuyAMERICAN INTL GROUP INC*w exp 01/19/202$47,677
+20.0%
2,550,917
+20.1%
0.65%
+12.7%
BATRK NewLIBERTY MEDIA CORP DELAWARE$43,8922,994,010
+100.0%
0.60%
 THERAVANCE INCnote 2.125% 1/1$38,926
+3.1%
48,230,0000.0%0.53%
-3.1%
SRAQ NewSILVER RUN ACQUISITION CORPcl a$36,7503,750,000
+100.0%
0.50%
PRTK BuyPARATEK PHARMACEUTICALS INC$28,439
+21.4%
2,044,498
+32.4%
0.39%
+14.2%
CASC NewCASCADIAN THERAPEUTICS INC$23,57825,000,000
+100.0%
0.32%
CACC NewCREDIT ACCEP CORP MICH$18,508100,000
+100.0%
0.25%
RUN  SUNRUN INC$16,889
-8.5%
2,848,0820.0%0.23%
-14.2%
OZM NewOCH ZIFF CAP MGMT GROUPcl a$12,8213,373,891
+100.0%
0.17%
BATRA NewLIBERTY MEDIA CORP DELAWARE$12,032800,000
+100.0%
0.16%
KIN  KINDRED BIOSCIENCES INC$10,669
+2.6%
3,013,8480.0%0.14%
-3.3%
OREX  OREXIGEN THERAPEUTICS INC$9,575
-23.6%
22,268,3990.0%0.13%
-28.2%
CWSA  CITIGROUP INC*w exp 01/04/201$6,031
-41.2%
102,553,2070.0%0.08%
-44.6%
NCQ  NOVACOPPER INC$5,300
+31.6%
10,600,7580.0%0.07%
+24.1%
SRAQW NewSILVER RUN ACQUISITION CORP*w exp 02/23/202$1,4251,250,000
+100.0%
0.02%
GNW ExitGENWORTH FINL INC$0-1,699,195
-100.0%
-0.07%
ExitCHESAPEAKE ENERGY CORPnote 2.500% 5/1$0-11,500,000
-100.0%
-0.10%
BXE ExitBELLATRIX EXPLORATION LTD$0-8,653,281
-100.0%
-0.13%
LQ ExitLA QUINTA HLDGS INC$0-1,111,000
-100.0%
-0.20%
ExitCHESAPEAKE ENERGY CORPnote 2.500% 5/1$0-23,300,000
-100.0%
-0.21%
BITI ExitBIOTIE THERAPIES OYJsponsored adr$0-1,395,000
-100.0%
-0.53%
SRAQU ExitSILVER RUN ACQUISITION CORPunit 99/99/9999t$0-3,750,000
-100.0%
-0.56%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • James F. Mooney III — Partner

Compare quarterly holdings

Export Baupost Group's holdings

EDGAR filings